Skip to main content
NCBI home page
Archives of Disease in Childhood logoLink to Archives of Disease in Childhood
. 1985 Jun;60(6):568–571. doi: 10.1136/adc.60.6.568

Luteinising hormone releasing hormone for incomplete descent of the testis.

A M Klidjian, P G Swift, J M Johnstone
PMCID: PMC1777369  PMID: 2861791

Abstract

Forty boys with 54 incompletely descended testes took part in a double blind, controlled trial of intranasal luteinising hormone releasing hormone. In the control (placebo) group of 18 boys there was no significant change in testicular descent and all required orchidopexy; in the 22 treated boys, however, 12 of 29 testes (42%) were found in a lower position. This study supports the idea that a trial of intranasal luteinising hormone releasing hormone (1200 micrograms/day for 28 days) will help clarify the need for orchidopexy in at least 30% of boys with incomplete descent of the testis, particularly those in whom the testes have emerged from the inguinal canal.

Full text

PDF
568

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bartsch G., Frick J. Therapeutic effects of luteinizing hormone releasing hormone (LH-RH) in cryptorchidism. Andrologia. 1974;6(3):197–201. doi: 10.1111/j.1439-0272.1974.tb01202.x. [DOI] [PubMed] [Google Scholar]
  2. Bertelsen A., Skakkebaek N. E., Mauritzen K., Preuss P., Pedersen P. V., Thorup J. Intranasalt gonadotropinfrigørende hormon (LH-RH) som behandling ved retentio testis. Ugeskr Laeger. 1981 Jun 15;143(25):1595–1597. [PubMed] [Google Scholar]
  3. Ehrlich R. M., Dougherty L. J., Tomashefsky P., Lattimer J. K. Effect of gonadotropin in cryptorchism. J Urol. 1969 Dec;102(6):793–795. doi: 10.1016/s0022-5347(17)62254-7. [DOI] [PubMed] [Google Scholar]
  4. Hadziselimović F., Girard J., Herzog B., Stalder G. Hormonal treatment of cryptorchidism. Horm Res. 1982;16(3):188–192. doi: 10.1159/000179501. [DOI] [PubMed] [Google Scholar]
  5. Happ J., Kollmann F., Krawehl C., Neubauer M., Beyer J. Intranasal GnRH therapy of maldescended testes. Horm Metab Res. 1975 Sep;7(5):440–441. doi: 10.1055/s-0028-1095673. [DOI] [PubMed] [Google Scholar]
  6. Happ J., Kollmann F., Krawehl C., Neubauer M., Krause U., Demisch K., Sandow J., Von Rechenberg W., Beyer J. Treatment of cryptorchidism with pernasal gonadotropin-releasing hormone therapy. Fertil Steril. 1978 May;29(5):546–551. doi: 10.1016/s0015-0282(16)43283-8. [DOI] [PubMed] [Google Scholar]
  7. Illig R., Exner G. U., Kollmann F., Kellerer K., Borkenstein M., Lunglmayr L., Kuber W., Prader A. Treatment of cryptorchidism by intranasal synthetic luteinising-hormone releasing hormone. Results of a collaborative double-blind study. Lancet. 1977 Sep 10;2(8037):518–520. doi: 10.1016/s0140-6736(77)90661-4. [DOI] [PubMed] [Google Scholar]
  8. Pirazzoli P., Zappulla F., Bernardi F., Villa M. P., Aleksandrowicz D., Scandola A., Stancari P., Cicognani A., Cacciari E. Luteinising hormone-releasing hormone nasal spray as therapy for undescended testicle. Arch Dis Child. 1978 Mar;53(3):235–238. doi: 10.1136/adc.53.3.235. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. REA C. E. Fertility in cryptorchids. Minn Med. 1951 Mar;34(3):216–217. [PubMed] [Google Scholar]
  10. Spitz L. Maldescent of the testis. Arch Dis Child. 1983 Nov;58(11):847–848. doi: 10.1136/adc.58.11.847. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. White M. C., Ginsburg J. Treatment of cryptorchidism by synthetic luteinising-hormone-releasing hormone. Lancet. 1977 Dec 24;2(8052-8053):1361–1361. doi: 10.1016/s0140-6736(77)90413-5. [DOI] [PubMed] [Google Scholar]

Articles from Archives of Disease in Childhood are provided here courtesy of BMJ Publishing Group

RESOURCES